July/August 2016 | Kimberly D. Miller, MPH; Rebecca L. Siegel, MPH; Chun Chieh Lin, PhD, MBA; Angela B. Mariotto, PhD; Joan L. Kramer, MD; Julia H. Rowland, PhD; Kevin D. Stein, PhD; Rick Alteri, MD; Ahmetin Jemal, DVM, PhD
The number of cancer survivors in the United States is increasing due to advances in early detection and treatment, as well as an aging population. As of January 1, 2016, over 15.5 million Americans with a history of cancer were alive, projected to reach 20.3 million by 2026. The most prevalent cancers in 2016 were prostate, colon and rectum, and melanoma in males, and breast, uterine corpus, and colon and rectum in females. Over half of survivors were diagnosed within the past 10 years, and nearly half were aged 70 or older. Cancer survivors have unique medical and psychosocial needs that require proactive management by primary care providers. Treatment patterns and survival rates vary by cancer type, with survival rates improving over time due to better treatments and earlier detection.
Breast cancer survivors are predominantly aged 60 or older, with 75% of survivors aged 60 or older. Treatment options include breast-conserving surgery or mastectomy, with mastectomy being more common for certain cases. Survival rates for breast cancer have improved significantly over the past 30 years. However, disparities exist between racial groups, with black women less likely to be diagnosed at a localized stage and having lower survival rates.
Colon and rectum cancer survivors are predominantly aged 60 or older, with 85% of survivors in this age group. Treatment options include surgery, chemotherapy, and radiation, with survival rates improving over time. Survivors may experience long-term health effects such as neuropathy, chronic diarrhea, and bowel dysfunction.
Leukemias and lymphomas are among the most common cancers in children and adolescents, with survival rates improving over time. Treatment options vary by cancer type, with some cancers requiring more aggressive treatments. Survivors may experience long-term health effects such as infertility, cognitive impairment, and chronic health conditions.
Lung cancer is the most common cancer in men, with survival rates improving over time. Treatment options include surgery, chemotherapy, and radiation, with survival rates varying by stage. Survivors may experience long-term health effects such as impaired pulmonary function and increased risk of smoking-related cancers.
Melanoma is the most common skin cancer, with survival rates improving over time. Treatment options include surgery, immunotherapy, and targeted therapy. Survivors may experience long-term health effects such as additional melanomas and autoimmune-related side effects.
Prostate cancer is the most common cancer in men, with survival rates improving over time. Treatment options include surgery, radiation, and hormone therapy. Survivors may experience long-term health effects such as urinary incontinence, erectile dysfunction, and bowel complications.
Testicular cancer is the most common cancer in men under 40, with survival rates improving over time. Treatment options include surgery, radiation, and chemotherapy. Survivors may experience long-term health effects such as infertility and retrograde ejaculation.The number of cancer survivors in the United States is increasing due to advances in early detection and treatment, as well as an aging population. As of January 1, 2016, over 15.5 million Americans with a history of cancer were alive, projected to reach 20.3 million by 2026. The most prevalent cancers in 2016 were prostate, colon and rectum, and melanoma in males, and breast, uterine corpus, and colon and rectum in females. Over half of survivors were diagnosed within the past 10 years, and nearly half were aged 70 or older. Cancer survivors have unique medical and psychosocial needs that require proactive management by primary care providers. Treatment patterns and survival rates vary by cancer type, with survival rates improving over time due to better treatments and earlier detection.
Breast cancer survivors are predominantly aged 60 or older, with 75% of survivors aged 60 or older. Treatment options include breast-conserving surgery or mastectomy, with mastectomy being more common for certain cases. Survival rates for breast cancer have improved significantly over the past 30 years. However, disparities exist between racial groups, with black women less likely to be diagnosed at a localized stage and having lower survival rates.
Colon and rectum cancer survivors are predominantly aged 60 or older, with 85% of survivors in this age group. Treatment options include surgery, chemotherapy, and radiation, with survival rates improving over time. Survivors may experience long-term health effects such as neuropathy, chronic diarrhea, and bowel dysfunction.
Leukemias and lymphomas are among the most common cancers in children and adolescents, with survival rates improving over time. Treatment options vary by cancer type, with some cancers requiring more aggressive treatments. Survivors may experience long-term health effects such as infertility, cognitive impairment, and chronic health conditions.
Lung cancer is the most common cancer in men, with survival rates improving over time. Treatment options include surgery, chemotherapy, and radiation, with survival rates varying by stage. Survivors may experience long-term health effects such as impaired pulmonary function and increased risk of smoking-related cancers.
Melanoma is the most common skin cancer, with survival rates improving over time. Treatment options include surgery, immunotherapy, and targeted therapy. Survivors may experience long-term health effects such as additional melanomas and autoimmune-related side effects.
Prostate cancer is the most common cancer in men, with survival rates improving over time. Treatment options include surgery, radiation, and hormone therapy. Survivors may experience long-term health effects such as urinary incontinence, erectile dysfunction, and bowel complications.
Testicular cancer is the most common cancer in men under 40, with survival rates improving over time. Treatment options include surgery, radiation, and chemotherapy. Survivors may experience long-term health effects such as infertility and retrograde ejaculation.